Title: Context-Dependent Effects of Amplified MAPK Signaling during Lung Adenocarcinoma Initiation and Progression.
Authors: Cicchini, Michelle; Buza, Elizabeth L; Sagal, Kyra M; Gudiel, A Andrea; Durham, Amy C; Feldser, David M
Published In Cell Rep, (2017 Feb 21)
Abstract: Expression of oncogenic KrasG12D initiates lung adenomas in a mitogen-activated protein kinase (MAPK) signal-dependent manner from only a subset of cell types in the adult mouse lung. Amplification of MAPK signaling is associated with progression to malignant adenocarcinomas, but whether this is a cause or a consequence of disease progression is not known. To better understand the effects of MAPK signaling downstream of KrasG12D expression, we capitalized on the ability of Braf inhibition to selectively amplify MAPK pathway signaling in KrasG12D-expressing epithelial cells. MAPK signal amplification indeed promoted the rapid progression of established adenomas to malignant adenocarcinomas. However, we observed, surprisingly, a greater number of overall tumor-initiating events after MAPK signal amplification, due to induced proliferation of cell types that are normally refractory to KrasG12D-induced transformation. Thus, MAPK signaling in the lung is thresholded not only during malignant progression but also at the moment of tumor initiation.
PubMed ID: 28228261
MeSH Terms: Adenocarcinoma of Lung; Adenocarcinoma/metabolism*; Adenocarcinoma/pathology*; Animals; Carcinogenesis/metabolism; Carcinogenesis/pathology; Cell Proliferation/physiology; Cell Transformation, Neoplastic/metabolism*; Cell Transformation, Neoplastic/pathology*; Disease Progression; Lung Neoplasms/metabolism*; Lung Neoplasms/pathology*; MAP Kinase Signaling System/physiology; Mice; Mitogen-Activated Protein Kinases/metabolism*; Proto-Oncogene Proteins B-raf/metabolism; Proto-Oncogene Proteins p21(ras)/metabolism; Signal Transduction/physiology*